Voyager Therapeutics (VYGR) FCF Margin (2015 - 2026)
Voyager Therapeutics (VYGR) reported FCF Margin of 1289.36% for Q1 2026, down 69376.0% on a YoY basis from N/an in Q1 2025, and down 590.2% sequentially from 186.81% in Q4 2025.
Voyager Therapeutics (VYGR) FCF Margin (2015 - 2026) Analysis & Trends
Voyager Therapeutics (VYGR) has 12 years of FCF Margin data on file, last reported at 1289.36% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 69376.0% year-over-year to 1289.36%; the trailing twelve-month figure through Mar 2026 stood at 349.76% (down 17637.0% YoY), and the FY2025 full-year result was 329.16%, down 30562.0% from the prior year.
- FCF Margin fell to 1289.36% in Q1 2026, from 186.81% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 5197.26% in Q1 2022 to a low of 2580.06% in Q2 2022.
- A 5-year average of 9.89% and a median of 117.23% in 2024 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin surged 553058 bps in 2022 and tumbled 511549 bps in 2023, its largest moves.
- Tracing VYGR's FCF Margin over 5 years: stood at 850.13% in 2022, then sank by 103 bps to 27.21% in 2023, then slumped by 757 bps to 233.04% in 2024, then gained by 20 bps to 186.81% in 2025, then plunged by 590 bps to 1289.36% in 2026.
- Business Quant data shows VYGR's FCF Margin at 1289.36% in Q1 2026, 186.81% in Q4 2025, and 233.86% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - | -1,289.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,289.36% |
| Dec 31, 2025 | -186.81% |
| Sep 30, 2025 | -233.86% |
| Jun 30, 2025 | -660.88% |
| Mar 31, 2025 | -595.60% |
| Dec 31, 2024 | -233.04% |
| Sep 30, 2024 | -114.60% |
| Jun 30, 2024 | -117.23% |
| Mar 31, 2024 | 301.29% |
| Dec 31, 2023 | -27.21% |
| Sep 30, 2023 | -509.32% |
| Jun 30, 2023 | -7.71% |
| Mar 31, 2023 | 81.78% |
| Dec 31, 2022 | 850.13% |
| Sep 30, 2022 | -42.96% |
| Jun 30, 2022 | -2,580.06% |
| Mar 31, 2022 | 5,197.26% |
| Dec 31, 2021 | 39.35% |
| Sep 30, 2021 | -1,352.09% |
| Jun 30, 2021 | -1,690.79% |